Commonwealth Equity Services’s Candel Therapeutics CADL Stock Holding History

Commonwealth Equity Services’s Portfolio CADL Stock Details CADL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.19M	Buy	115,875 +20,480	+21%	+$155K	﹤0.01%	2581
2026 Q1	$467K	Buy	95,395 +13,049	+16%	+$71K	﹤0.01%	3270
2025 Q4	$465K	Buy	82,346 +125	+0.2%	+$672	﹤0.01%	3225
2025 Q3	$419K	Buy	82,221 +620	+0.8%	+$3.58K	﹤0.01%	3334
2025 Q2	$413K	Buy	81,601 +16,529	+25%	+$85.1K	﹤0.01%	3318
2025 Q1	$368K	Buy	65,072 +23,974	+58%	+$196K	﹤0.01%	3302
2024 Q4	$357K	Buy	+41,098	New	+$243K	﹤0.01%	3257
2024 Q2	–	Sell	-14,182	Closed	-$22K	–	4060
2024 Q1	$22K	Buy	+14,182	New	+$21.1K	﹤0.01%	3956

Other funds holding CADL

TWM

Tanager Wealth Management Goring On Thames, United Kingdom $1.15B AUM 19.91% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

TGIA

Torrey Growth & Income Advisors Del Mar, California $294M AUM 37.95% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Commonwealth Equity Services's CADL Position: Q2 2026 in Review

Commonwealth Equity Services increased its Candel Therapeutics (CADL) stake by 21% in Q2 2026, buying an estimated $155K and bringing the position to 115,875 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2581.

Commonwealth Equity Services first reported a position in CADL in Q1 2024 and has held it in 8 quarters since. 22 funds tracked by Wall St. Rank hold CADL as of Q2 2026.

Commonwealth Equity Services held 115,875 shares of Candel Therapeutics worth $1.19M as of Q2 2026.
Commonwealth Equity Services bought 20,480 Candel Therapeutics shares in Q2 2026, an estimated $155K.
Candel Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2581 holding.
Commonwealth Equity Services first reported a position in Candel Therapeutics in Q1 2024 and has held it in 8 quarters since.
22 funds tracked by Wall St. Rank held Candel Therapeutics as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.